PMC:7499654 / 107-830
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 198-210 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T3 | 307-319 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T4 | 361-374 | Body_part | denotes | cell surfaces | http://purl.org/sig/ont/fma/fma67653 |
T5 | 361-365 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T2 | 22-30 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T3 | 62-70 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 234-243 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 82-83 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T2 | 115-120 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T3 | 355-365 | http://purl.obolibrary.org/obo/CLO_0053065 | denotes | human cell |
T4 | 682-683 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T2 | 198-210 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T3 | 307-319 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T4 | 320-331 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T5 | 606-615 | Chemical | denotes | N-glycans | http://purl.obolibrary.org/obo/CHEBI_59520 |
T6 | 608-615 | Chemical | denotes | glycans | http://purl.obolibrary.org/obo/CHEBI_18154 |
T7 | 641-649 | Chemical | denotes | LacdiNAc | http://purl.obolibrary.org/obo/CHEBI_61190 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 512-525 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
T2 | 699-714 | http://purl.obolibrary.org/obo/GO_0006493 | denotes | O-glycosylation |
T3 | 701-714 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-166 | Sentence | denotes | The novel coronavirus SARS-CoV-2, the infective agent causing COVID-19, is having a global impact both in terms of human disease as well as socially and economically. |
T5 | 167-375 | Sentence | denotes | Its heavily glycosylated spike glycoprotein is fundamental for the infection process, via its receptor binding domains interaction with the glycoprotein angiotensin converting enzyme 2 on human cell surfaces. |
T6 | 376-561 | Sentence | denotes | We therefore utilized an integrated glycomic and glycoproteomic analytical strategy to characterise both N- and O- glycan site specific glycosylation within the receptor binding domain. |
T7 | 562-723 | Sentence | denotes | We demonstrate the presence of complex type N-glycans with unusual fucosylated LacdiNAc at both sites N331 and N343 and a single site of O-glycosylation on T323. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
13 | 320-351 | Gene | denotes | angiotensin converting enzyme 2 | Gene:59272 |
14 | 4-21 | Species | denotes | novel coronavirus | Tax:2697049 |
15 | 22-32 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
16 | 115-120 | Species | denotes | human | Tax:9606 |
17 | 355-360 | Species | denotes | human | Tax:9606 |
18 | 481-497 | Chemical | denotes | N- and O- glycan | |
19 | 606-615 | Chemical | denotes | N-glycans | |
20 | 664-668 | Chemical | denotes | N331 | |
21 | 673-677 | Chemical | denotes | N343 | |
22 | 62-70 | Disease | denotes | COVID-19 | MESH:C000657245 |
23 | 234-243 | Disease | denotes | infection | MESH:D007239 |